|
|
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
Attachment 3 ??? Number of BPD Reports by Type of Non-Blood Manufacturer (FY04)1BPD CODES Allergenic Derivative In-Vitro Diagnostic Therapeutic VaccineINCOMING MATERIAL IM1201 0 IM1202 1 IM ... more>>
FDADocs 5/9/2008 | 0 (0) | 12 | 0 | 0 | English
Attachment 1 ??? FY05: Number of BPD Reports by Type of Blood Establishment Licensed Blood Establishments Unlicensed Blood Establishments ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 11 | 0 | 0 | English
fJtkMXJIDANCE FOR THE 3JlXiSSION O FCABINET X-RAY SYSTEM REPORTS PURSUANT TO 21 CFR 1020.40vCompiled by:Ili visionCompliance X-flay Pmducts BrarichofFEBRUARY 1975U ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
AgreementConsumer Healthcare Products Association (CHPA) and FDA2Steering CommitteeAbimbola Abedowale, FDA Sandy Barnes, FDA Greg Collier, Procter & Gamble Carmen Debellas, FDA Robert ... more>>
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
Attachment 1 ??? Number of BPD Reports by Type of Blood Establishment (FY04) Licensed Blood BPD CODES Establishments Unlicensed Blood Transfusion Establishments Services ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
June 8.2004\NATfONALStatement before the FDA Food Advisory Committee Contaminants and Natural Toxicants Subcommittee Meeting June 8,2004 by Richard Jarman Vice Preslden~ Food and ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
Administration (FDA) is proposing to amend its investigational new drug application (IND) regulation concerning charging patients for investigational new drugs . FDA is proposing to revise the current charging ... more>>
|